Literature DB >> 28436976

RBC depletion from a PBSC graft.

H Bonig1,2,3, G Bug4.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28436976     DOI： 10.1038/bmt.2017.72

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Bone marrow processing for transplantation using the COBE spectra cell separator.

Authors:  Z Korístek; J Mayer
Journal:  J Hematother Stem Cell Res       Date:  1999-08

2.  Hemopoietic stem cell processing: comparison of progenitor cell recovery using the Cobe 2991 cell washer and the Haemonetics V50 apheresis system.

Authors:  R A Preti; T Ahmed; J Ayello; L Helson; I Argani; D Wuest; D Ciavarella
Journal:  Bone Marrow Transplant       Date:  1992-05       Impact factor: 5.483

3.  Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE Spectra cell separator before haematopoietic stem cell transplantation.

Authors:  M G Guttridge; C Sidders; E Booth-Davey; D Pamphilon; S M Watt
Journal:  Bone Marrow Transplant       Date:  2006-06-12       Impact factor: 5.483

4.  Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.

Authors:  Nicolas Blin; Richard Traineau; Stéphanie Houssin; Régis Peffault de Latour; Anna Petropoulou; Marie Robin; Jérôme Larghero; Patricia Ribaud; Gérard Socié
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-29       Impact factor: 5.742

5.  How do I approach ABO-incompatible hematopoietic progenitor cell transplantation?

Authors:  Jennifer Daniel-Johnson; Joseph Schwartz
Journal:  Transfusion       Date:  2011-03-07       Impact factor: 3.157

6.  Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologies.

Authors:  Nadine Sorg; Carolin Poppe; Milica Bunos; Eva Wingenfeld; Christiane Hümmer; Ariane Krämer; Belinda Stock; Erhard Seifried; Halvard Bonig
Journal:  Transfusion       Date:  2015-02-02       Impact factor: 3.157

7.  Human bone marrow processing using Cobe 2991 and CS 3000 blood cell separators for further ex vivo manipulation.

Authors:  A Angelini; A Dragani; A Iacone; D D'Antonio; P Accorsi; A M Quaglietta; A Berardi; G Fioritoni; P Di Bartolomeo; G D'Emilio
Journal:  Haematologica       Date:  1990 Jan-Feb       Impact factor: 9.941

8.  Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation.

Authors:  J G Kim; S K Sohn; D H Kim; J H Baek; K B Lee; W S Min; C C Kim; M H Lee; J-J Lee; I-J Chung; H-J Kim; J W Lee
Journal:  Bone Marrow Transplant       Date:  2005-03       Impact factor: 5.483

9.  ABO-incompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion.

Authors:  H A Blacklock; M J Gilmore; H G Prentice; G R Hazlehurst; J P Evans; D D Ma; C B Knight; A V Hoffbrand
Journal:  Lancet       Date:  1982-11-13       Impact factor: 79.321

10.  Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processor.

Authors:  N R Jin; R Hill; G Segal; B Still; F B Petersen; D Amos; C D Buckner; R Clift; W Bensinger; P Martin
Journal:  Exp Hematol       Date:  1987-01       Impact factor: 3.084
  10 in total
  2 in total

1.  ABO incompatibile graft management in pediatric transplantation.

Authors:  Adriana Balduzzi; Halvard Bönig; Andrea Jarisch; Tiago Nava; Marc Ansari; Alessandro Cattoni; Giulia Prunotto; Giovanna Lucchini; Gergely Krivan; Toni Matic; Krzyzstof Kalwak; Akif Yesilipek; Marianne Ifversen; Peter Svec; Jochen Buechner; Kim Vettenranta; Roland Meisel; Anita Lawitschka; Christina Peters; Brenda Gibson; Arnaud Dalissier; Selim Corbacioglu; André Willasch; Jean-Hugues Dalle; Peter Bader
Journal:  Bone Marrow Transplant       Date:  2020-06-27       Impact factor: 5.483

2.  Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMC.

Authors:  Soo-Zin Kim-Wanner; Gesine Bug; Juliane Steinmann; Salem Ajib; Nadine Sorg; Carolin Poppe; Milica Bunos; Eva Wingenfeld; Christiane Hümmer; Beate Luxembourg; Erhard Seifried; Halvard Bonig
Journal:  J Transl Med       Date:  2017-08-11       Impact factor: 5.531
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.